L'Oréal appoints Merck Serono's CEO to board of directors

DARMSTADT, Germany and PARIS — President and CEO of Merck Serono, Belén Garijo, has been appointed an independent director of L'Oréal.



Garijo was appointed to the four-year term during L’Oréal’s 2014 Annual General Meeting held Thursday in Paris.



Garijo is a doctor specializing in clinical pharmacology and internal medicine. She joined Merck Serono, the biopharmaceutical division of Merck, in 2011. During her 25-year career in the pharmaceutical industry, she has held diverse senior functions in a number of countries. She worked in research for eight years before moving to commercial functions of increasing responsibility. Before joining the pharmaceutical industry, she worked for six years as a practicing physician.